196 related articles for article (PubMed ID: 20927048)
1. Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects.
Banas SM; Doly S; Boutourlinsky K; Diaz SL; Belmer A; Callebert J; Collet C; Launay JM; Maroteaux L
Neuropsychopharmacology; 2011 Jan; 36(2):423-33. PubMed ID: 20927048
[TBL] [Abstract][Full Text] [Related]
2. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension.
Launay JM; Hervé P; Peoc'h K; Tournois C; Callebert J; Nebigil CG; Etienne N; Drouet L; Humbert M; Simonneau G; Maroteaux L
Nat Med; 2002 Oct; 8(10):1129-35. PubMed ID: 12244304
[TBL] [Abstract][Full Text] [Related]
3. 5-HT(2B) receptors are required for serotonin-selective antidepressant actions.
Diaz SL; Doly S; Narboux-Nême N; Fernández S; Mazot P; Banas SM; Boutourlinsky K; Moutkine I; Belmer A; Roumier A; Maroteaux L
Mol Psychiatry; 2012 Feb; 17(2):154-63. PubMed ID: 22158014
[TBL] [Abstract][Full Text] [Related]
4. Implication of 5-HT(2B) receptors in the serotonin syndrome.
Diaz SL; Maroteaux L
Neuropharmacology; 2011 Sep; 61(3):495-502. PubMed ID: 21277875
[TBL] [Abstract][Full Text] [Related]
5. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs.
Gardier AM; Kaakkola S; Erfurth A; Wurtman RJ
Brain Res; 1992 Aug; 588(1):67-74. PubMed ID: 1382807
[TBL] [Abstract][Full Text] [Related]
6. Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats.
Rowland NE; Robertson K; Lo J; Rema E
Psychopharmacology (Berl); 2001 Jun; 156(1):108-14. PubMed ID: 11465628
[TBL] [Abstract][Full Text] [Related]
7. Activation of hypothalamic insulin by serotonin is the primary event of the insulin-serotonin interaction involved in the control of feeding.
Orosco M; Rouch C; Gerozissis K
Brain Res; 2000 Jul; 872(1-2):64-70. PubMed ID: 10924676
[TBL] [Abstract][Full Text] [Related]
8. Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine.
Rowland NE; Marshall M; Robertson K
Eur J Pharmacol; 2001 May; 419(1):61-4. PubMed ID: 11348631
[TBL] [Abstract][Full Text] [Related]
9. The acute effects of dexfenfluramine on human and porcine pulmonary vascular tone and resistance.
Higenbottam T; Marriott H; Cremona G; Laude E; Bee D
Chest; 1999 Oct; 116(4):921-30. PubMed ID: 10531154
[TBL] [Abstract][Full Text] [Related]
10. Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine.
Cheetham SC; Viggers JA; Slater NA; Heal DJ
Neuropharmacology; 2000 Aug; 39(11):2028-35. PubMed ID: 10963746
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in mice.
Callebert J; Esteve JM; Hervé P; Peoc'h K; Tournois C; Drouet L; Launay JM; Maroteaux L
J Pharmacol Exp Ther; 2006 May; 317(2):724-31. PubMed ID: 16461587
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.
Lam DD; Przydzial MJ; Ridley SH; Yeo GS; Rochford JJ; O'Rahilly S; Heisler LK
Endocrinology; 2008 Mar; 149(3):1323-8. PubMed ID: 18039773
[TBL] [Abstract][Full Text] [Related]
13. Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine.
Higgins GA; Ouagazzal AM; Grottick AJ
Br J Pharmacol; 2001 Jun; 133(4):459-66. PubMed ID: 11399662
[TBL] [Abstract][Full Text] [Related]
14. Targeting 5-HT receptors for the treatment of obesity.
Sargent BJ; Henderson AJ
Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
[TBL] [Abstract][Full Text] [Related]
15. Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats.
Eddahibi S; Adnot S; Frisdal E; Levame M; Hamon M; Raffestin B
J Pharmacol Exp Ther; 2001 Apr; 297(1):148-54. PubMed ID: 11259539
[TBL] [Abstract][Full Text] [Related]
16. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
Davis R; Faulds D
Drugs; 1996 Nov; 52(5):696-724. PubMed ID: 9118819
[TBL] [Abstract][Full Text] [Related]
17. Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action.
De Vry J; Schreiber R
Neurosci Biobehav Rev; 2000 May; 24(3):341-53. PubMed ID: 10781694
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension.
Launay JM; Hervé P; Callebert J; Mallat Z; Collet C; Doly S; Belmer A; Diaz SL; Hatia S; Côté F; Humbert M; Maroteaux L
Blood; 2012 Feb; 119(7):1772-80. PubMed ID: 22186990
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
Laflamme N; Bovetto S; Richard D; Rivest S
Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
